These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8850130)
21. [Seroepidemiological survey of El Tor cholera in an endemic region of Algeria]. Bendib A; Nora M; Mahrouf H; Saib M; el Abassi K; Dodin A Bull Soc Pathol Exot; 1994; 87(3):143-7. PubMed ID: 7827512 [TBL] [Abstract][Full Text] [Related]
22. Vibriocidal antibody titer rise after rectal or anal administration of Vibrio cholerae in dogs. Nalin DR; Ahmed A Am J Gastroenterol; 1978 Apr; 69(4):453-7. PubMed ID: 685952 [TBL] [Abstract][Full Text] [Related]
23. [Diagnosis of Vibrio cholerae in the laboratory]. Dodin A; Goud B Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):644-51. PubMed ID: 6673858 [TBL] [Abstract][Full Text] [Related]
24. Murine marginal zone B cells play a role in Vibrio cholerae LPS antibody responses. Wade WF; King RG; Grandjean C; Wade TK; Justement LB Pathog Dis; 2014 Mar; 70(2):153-7. PubMed ID: 23966359 [TBL] [Abstract][Full Text] [Related]
25. Rapid screening of fecal samples for Vibrio cholerae by a coagglutination technique. Jesudason MV; Thangavelu CP; Lalitha MK J Clin Microbiol; 1984 May; 19(5):712-3. PubMed ID: 6736229 [TBL] [Abstract][Full Text] [Related]
26. [Determination of the activity of Vibrio cholerae antibodies in human and animal sera by means of the bactericidal test]. Rymkiewicz D Med Dosw Mikrobiol; 1976; 28(3):221-30. PubMed ID: 794601 [No Abstract] [Full Text] [Related]
27. Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses. Iyer AS; Azman AS; Bouhenia M; Deng LO; Anderson CP; Graves M; Kováč P; Xu P; Ryan ET; Harris JB; Sack DA; Luquero FJ; Leung DT PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006196. PubMed ID: 29377882 [TBL] [Abstract][Full Text] [Related]
28. Epidemiology of cholera--a five year study. Bajaj JK; Baradker VP; Joshi SG; Damle AS; Kayararte RP; Deshmukh AB J Commun Dis; 2001 Dec; 33(4):282-5. PubMed ID: 12561506 [TBL] [Abstract][Full Text] [Related]
32. Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a protein carrier. Chernyak A; Kondo S; Wade TK; Meeks MD; Alzari PM; Fournier JM; Taylor RK; Kovác P; Wade WF J Infect Dis; 2002 Apr; 185(7):950-62. PubMed ID: 11920320 [TBL] [Abstract][Full Text] [Related]
33. Typing and antibiotic susceptibility patterns of Vibrio cholerae during six consecutive cholera seasons in north India. Kaur H; Lal M Trop Gastroenterol; 1998; 19(2):59-61. PubMed ID: 9752752 [TBL] [Abstract][Full Text] [Related]
34. Vibriocidal assays to determine the antibody titer of patient sera samples. Son MS; Taylor RK Curr Protoc Microbiol; 2011 Nov; Chapter 6():Unit6A.3. PubMed ID: 22045586 [TBL] [Abstract][Full Text] [Related]
35. Incidence of Vibrio cholerae serogroup O139 infection with low virulence in Hubli, Karnataka (India). Krishna BV; Patil A; Nadgir SD; Chandrasekhar MR Indian J Pathol Microbiol; 2003 Jan; 46(1):142-4. PubMed ID: 15027758 [TBL] [Abstract][Full Text] [Related]
36. Serological studies in cholera infection in Calcutta (1966-67). Deb BC; Ganguly R; Sinho R; Ghosh AK; Succar BK; Abou-Gareeb AH; Ozawa A; Shrivastava DL; Burrows W Indian J Med Res; 1973 Feb; 61(2):169-78. PubMed ID: 4758991 [No Abstract] [Full Text] [Related]
37. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau. Qureshi K; Mølbak K; Sandström A; Kofoed PE; Rodrigues A; Dias F; Aaby P; Svennerholm AM Pediatr Infect Dis J; 2006 Dec; 25(12):1163-6. PubMed ID: 17133163 [TBL] [Abstract][Full Text] [Related]
38. [The current status of research on a cholera vaccine]. Fournier JM Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):412-5. PubMed ID: 10078377 [TBL] [Abstract][Full Text] [Related]
39. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005. Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957 [TBL] [Abstract][Full Text] [Related]
40. Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India. Krishna BV; Patil AB; Chandrasekhar MR Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):224-6. PubMed ID: 16246383 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]